Drugs & Targets G100 receives Orphan Drug Designation from EMA for follicular non-Hodgkin’s lymphoma October 27, 2017Vol.43 No.40
Drugs & Targets FDA Accepts BMS application for Opdivo for resected high-risk advanced melanoma October 20, 2017Vol.43 No.39
Drugs & Targets FDA grants priority review for Lilly’s Verzenio (abemaciclib) for advanced breast cancer October 13, 2017Vol.43 No.38
Drugs & Targets Janssen submits NDA for apalutamide in non-metastatic castration-resistant prostate cancer October 13, 2017Vol.43 No.38
Drugs & TargetsFree FDA approves sNDA for Alunbrig tablets, Takeda announces October 06, 2017Vol.43 No.37
Drugs & TargetsFree FDA grants priority review for Genentech’s Perjeta in adjuvant HER2+ early breast cancer October 06, 2017Vol.43 No.37
Drugs & TargetsFree Amgen, CytomX Therapeutics form immuno-oncology collaboration October 06, 2017Vol.43 No.37
